Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

HEROZ Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

HEROZ şirketinin toplam hissedar öz sermayesi ¥5.2B ve toplam borcu ¥1.8B olup, bu da borç-öz sermaye oranını 35.4% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ¥8.0B ve ¥2.8B dir. HEROZ 'in FAVÖK'ü ¥446.0M faiz karşılama oranı 44.6 dur. Şirketin ¥3.0B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

35.4%

Borç/özkaynak oranı

JP¥1.85b

Borç

Faiz karşılama oranı	44.6x
Nakit	JP¥3.02b
Eşitlik	JP¥5.23b
Toplam yükümlülükler	JP¥2.78b
Toplam varlıklar	JP¥8.01b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

HEROZ (TSE:4382) Might Be Having Difficulty Using Its Capital Effectively

Apr 05

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 4382 'nin kısa vadeli varlıkları ( ¥4.2B ) kısa vadeli yükümlülüklerini ( ¥1.1B ) aşıyor.

Uzun Vadeli Yükümlülükler: 4382 şirketinin kısa vadeli varlıkları ( ¥4.2B ) uzun vadeli yükümlülüklerini ( ¥1.6B ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 4382 şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: 4382 şirketinin borç/öz sermaye oranı son 5 yılda 14.2% seviyesinden 35.4% seviyesine yükseldi.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: Kârsız olan 4382 mevcut pozitif serbest nakit akışı seviyesini koruduğu takdirde 3 yıldan fazla yetecek nakit pistine sahip olacaktır.

Tahmini Nakit Akışı: 4382 kârlı değildir ancak serbest nakit akışı pozitif olsa ve yılda 163 % oranında azalsa bile 3 yıldan fazla bir süre yetecek nakit akışına sahiptir.

HEROZ Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

New minor risk - Profitability

New minor risk - Market cap size

Full year 2024 earnings: EPS misses analyst expectations

HEROZ, Inc. to Report Q1, 2025 Results on Sep 13, 2024

Full year 2024 earnings: EPS misses analyst expectations

HEROZ, Inc., Annual General Meeting, Jul 26, 2024

HEROZ, Inc. to Report Fiscal Year 2024 Results on Jun 14, 2024

HEROZ (TSE:4382) Might Be Having Difficulty Using Its Capital Effectively

HEROZ, Inc. Provides Consolidated Earnings Forecast for the Fiscal Year Ending April 30, 2024

Third quarter 2024 earnings released: JP¥59.24 loss per share (vs JP¥3.73 loss in 3Q 2023)

HEROZ, Inc. to Report Q3, 2024 Results on Mar 08, 2024

Second quarter 2024 earnings released: EPS: JP¥1.13 (vs JP¥3.73 loss in 2Q 2023)

New major risk - Share price stability

HEROZ, Inc. (TSE:4382) agreed to acquire 50.1% stake in A.I. Squared, Inc. from BroadBand Tower,Media Do Corporation, Masaki Ishida and Akihito Ogino.

HEROZ, Inc. (TSE:4382) agreed to acquire 50.1% stake in A.I. Squared, Inc. from BroadBand Tower,Media Do Corporation, Masaki Ishida and Akihito Ogino.

HEROZ, Inc. to Report Q2, 2024 Results on Dec 08, 2023

First quarter 2024 earnings released: JP¥3.13 loss per share (vs JP¥3.73 loss in 1Q 2023)

HEROZ, Inc. to Report Q1, 2024 Results on Sep 08, 2023

HEROZ, Inc. Provides Consolidated Earnings Forecast for the Fiscal Year Ending April 30, 2024

HEROZ, Inc., Annual General Meeting, Jul 27, 2023

Third quarter 2023 earnings released: JP¥0.33 loss per share (vs JP¥0.53 profit in 3Q 2022)

HEROZ, Inc. to Report Q3, 2023 Results on Mar 10, 2023

Heroz, Inc. Revises Consolidated Earnings Forecast for the Fiscal Year Ending April 30, 2023

HEROZ, Inc. Provides Consolidated Sales Guidance for the Fiscal Year Ending April 30, 2023

Second quarter 2023 earnings released: JP¥34.61 loss per share (vs JP¥0.86 loss in 2Q 2022)

No independent directors

HEROZ, Inc. to Report Q2, 2023 Results on Dec 09, 2022

HEROZ, Inc. Provides Consolidated Sales Guidance for the Fiscal Year Ending April 30, 2023

First quarter 2023 earnings released: EPS: JP¥0.47 (vs JP¥0.20 in 1Q 2022)

HEROZ, Inc. (TSE:4382) agreed to acquire 86.5% stake in Strategit Co., Ltd. from First Advisors Investment Partnership No. 3, Kei Tachihara and James Joshua Enrique.

Full year 2022 earnings released: EPS: JP¥3.26 (vs JP¥13.84 in FY 2021)

HEROZ, Inc. to Report Q1, 2023 Results on Sep 09, 2022

Heroz, Inc. Provides Non-Consolidated Financial Results Guidance for the Year Ending April 30, 2023

Full year 2022 earnings released: EPS: JP¥3.26 (vs JP¥13.84 in FY 2021)

HEROZ, Inc., Annual General Meeting, Jul 28, 2022

No independent directors

HEROZ, Inc. to Report Fiscal Year 2022 Results on Jun 10, 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

HEROZ, Inc. Provides Non-Consolidated Financial Guidance for the Year Ending April 30, 2022

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

HEROZ, Inc. Provides Non-Consolidated Earnings Guidance for the Full Year Ending April 30, 2022

HEROZ, Inc. (TSE:4382) entered into a share transfer agreement to acquire 32.31% stake in Vario Secure Inc. (TSE:4494) from iSigma Business Advancement Fund 2, managed by iSigma Partners Corporation for ¥1.9 billion.

Full year 2021 earnings released: EPS JP¥13.84 (vs JP¥17.81 in FY 2020)

HEROZ, Inc. Announces Non-Consolidated Earnings Guidance for the Year Ending April 30, 2022

Full year 2021 earnings released: EPS JP¥13.84 (vs JP¥17.81 in FY 2020)

Third quarter 2021 earnings released: EPS JP¥2.68 (vs JP¥2.77 in 3Q 2020)

New 90-day high: JP¥3,160

HEROZ, Inc. to Report Q3, 2021 Results on Mar 12, 2021

New 90-day low: JP¥2,822

Second quarter 2021 earnings released: EPS JP¥3.62

HEROZ, Inc. to Report Q2, 2021 Results on Dec 11, 2020

HEROZ, Inc. to Report Q1, 2021 Results on Sep 11, 2020

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin